ALLO compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

ALLOAllogene Therapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

ALLOAllogene Therapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ALLO 12

PFEPfizersupplier

NTRANaterasupplier

CLLSCellectissupplier

—Arbor Biotechnologiesunlistedsupplier

8 more · ALLO chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

ALLOAllogene Therapeutics, Inc.

1.04▼−4.59%· post 1.07

Mkt cap$360.3MRevenue$5MQ2 FY26Revenue—

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

ClosedNov 6 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

ClosedNov 6 '26

ALLOAllogene Therapeutics, Inc.

AMGNAmgen Inc

1.04▼−4.59%post 1.07

Price

460.55▲+0.06%post 460.42

$360.3M

Mkt cap

$249.0B

Q2 FY26$5M

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

ALLO1.04▼−4.59%vsAMGN460.55▲+0.06%ClosedNov 6 '26